anticomplement

anticomplement

 [an″te-, an″ti-kom´plĕ-ment]
a substance that counteracts the action of a complement.

an·ti·com·ple·ment

(an'tē-kom'plĕ-ment),
A substance that combines with a complement component and neutralizes its action by preventing its union with an antibody.
Synonym(s): antialexin

an·ti·com·ple·ment

(an'tē-kom'plĕ-mĕnt)
A substance that combines with complement and neutralizes its action by preventing its union with an antibody.
References in periodicals archive ?
Many cytomegalovirus assay are used for the detection of CMV IgG antibodies such as enzyme-linked immunosorbent assay (ELISA), indirect hemagglutination, radioimmunoassay and anticomplement immunofluorescence.
Animal models should be the next very useful step to monitor ALF therapy since knockout studies using anticomplement antibodies, small interfering RNAs, and recombinant complement protein may be useful to evaluate the function of complements on cell proliferation and apoptosis.
-- [63] Ipomoea batatas -- [64] Koelreuteria paniculata Antioxidant [65] Allium ampeloprasum Antioxidant [66] Ligusticum chuanxiong -- [67] Lindera aggregate -- [68] Litsea coreana Antioxidant [69] Magnolia fargesii Anticomplement [70] Moringa oleifera Lam.
This case emphasises the need to develop a strategy for monitoring treatment efficacy and potential individualisation of anticomplement therapy.
In this study, for the first time, the immune active anti-inflammatory mechanism of polysaccharide was proved through anticomplement, and the structure of S-3-1 was characterized as well.
It was reported that ginsenosides have antidiabetic, anti-inflammatory, antitumor activities, antiatheroscloresis effects and antitumor anticomplement activity in recent years [62].
Furthermore, we isolated and purified two homogeneous polysaccharides from S-3 fraction (S-3-1 and S-3-2), and we found that S-3-1 could significantly enhance the anticomplement activity and macrophage immunological activity in vitro.
Antibodies against other components of the complement system have also been identified, such as anti-CFH, anticomplement factor B (CFB), anti-C4, or anti-C3b [9].
Case studies and small trials have explored the plasma cell agent bortezomib or the anticomplement C5 agent eculizumab.
Ixodes ticks belonging to the Ixodes ricinus complex encode a family of anticomplement proteins.
As it was a retrospective study within 12 years, the high rate of treatment failure (59.6%), attributed to inappropriate therapy, such as low rate of plasma exchange and lack of anticomplement therapy, might also contribute to the poor prognosis.
Consequently, improvement in the renal function in response to anticomplement therapy is likely to be quite variable.